Walking away from heart failure blues: study tests 12-Week home program
NCT ID NCT06791967
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 12-week home-based walking program could help heart failure patients with depression, frailty, and quality of life. 68 patients were split into two groups: one got standard health education, the other added a walking routine of 3,000 extra steps per session, five times a week. Researchers measured changes in mood, frailty, and daily well-being over three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- home-based walking exercise program
- What this could lead to
- If successful, this walking program could offer a simple, low-cost way to improve mood, reduce frailty, and enhance quality of life for people with heart failure.
- What could go wrong
- This is a small, single-center study with only 68 participants. Results may not apply to all heart failure patients, and the program requires motivation to stick with it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
68 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed with heart failure classified as New York Heart Association (NYHA) Functional Class II-III by a physician. * Approval from the attending physician to participate in the home-based walking program after discharge. * Aged between 18 and 80 years. * Patients unable to attend outpatient cardiac rehabilitation. * No regular exercise habits, such as performing less than 30 minutes of aerobic exercise per week. * Able to walk independently without the aid of assistive devices. * Patients with clear consciousness, no cognitive impairment, and no history of mental illness. * Able to communicate in Mandarin or Taiwanese dialect. * Willing to participate in the study, sign the informed consent form, and comply with the home-based walking program. Exclusion Criteria: * Patients diagnosed with heart failure classified as New York Heart Association (NYHA) functional class IV by a physician. * Patients diagnosed with depression by a psychiatrist. * Patients with cognitive impairment or language communication disorders. * Patients who are bedridden for an extended period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a Hands-On reflex therapy steady an older Person's stance?
- Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
- Can a phone app that blocks distracting apps ease depression?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can teachers and a phone app ease teen depression?